신세포암의 자가 동종 종양세포 및 동종 또는 공여자 수지상세포 혼합백신의 개발 및 적용 = Development and Application of Mixed Vaccines in Renal Cell Carcinoma: Combining Autologous Tumor Cells with Dendritic Cells Derived from Autologous or Allogeneic Origin

참고문헌 (Reference)

1 전상현, "정상혈액 단핵구에서 수상돌기세포의 배양 및 신세포암 세포주로 자극한 수상돌기세포의 항암면역효과: In vitro 연구" 대한비뇨기과학회 43 (43): 795-801, 2002

2 박동수, "전이성 신세포암의 보조 면역치료로써 자가종양백신의 적용" 대한비뇨기과학회 46 (46): 1106-1109, 2005

3 Schuler G, "The use of dendritic cells in cancer immunotherapy" 15 : 138-147, 2003

4 Patel PH, "Targeted therapy for metastatic renal cell carcinoma" 94 : 614-619, 2006

5 Lam JS, "Surveillance following radical or partial nephrectomy for renal cell carcinoma" 6 : 7-18, 2005

6 Motzer RJ, "Sunitinib in patients with metastatic renal cell carcinoma" 295 : 2516-2524, 2006

7 Michael A, "Renal-cell carcinoma: tumour markers, T-cell epitopes, and potential for new therapies" 4 : 215-223, 2003

8 Mulders P, "Renal cell carcinoma: recent progress and future directions" 57 : 5189-5195, 1997

9 Russo P, "Renal cell carcinoma: presentation, staging, and surgical treatment" 27 : 160-176, 2000

10 Ng CS, "Mechanisms of immune evasion by renal cell carcinoma: tumor-induced T-lymphocyte apoptosis and NF-kappaB suppression" 59 : 9-14, 2002

11 Finke JH, "Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma" 53 : 5613-5616, 1993

12 Holtl L, "Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells" 8 : 3369-3376, 2002

13 Avigan D, "Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses" 10 : 4699-4708, 2004

14 Cardi G, "Expression of Fas(APO-1/ CD95) in tumor-infiltrating and peripheral blood lymphocytes in patients with renal cell carcinoma" 58 : 2078-2080, 1998

15 Sallusto F, "Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha" 179 : 1109-1118, 1994

16 Brossart P, "Dendritic cells in cancer vaccines" 29 : 1247-1255, 2001

17 Avigan D, "Dendritic cell-tumor fusion vaccines for renal cell carcinoma" 10 : 6347-6352, 2004

18 Flanigan RC, "Debulking nephrectomy in metastatic renal cancer" 10 : 6335-6341, 2004

19 Jemal A, "Cancer statistics, 2006" 56 : 106-130, 2006

20 Jocham D, "Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal- cell carcinoma after radical nephrectomy: phase III, randomised controlled trial" 363 : 594-599, 2004

21 Schwaab T, "A randomized phase II trial comparing two different sequence combinations of autologous vaccine and human recombinant of autologous vaccine and human recombinant interferon gamma and human recombinant interferon alpha2B therapy in patients with metastatic renal cell carcinoma: clinical outcome and analysis of immunological parameters" 163 : 1322-1327, 2000